Farfel Gail M

EVP/Chief Development Officer at ZOGENIX, INC.; Chief Clinical Dev & Reg Offic at MARINUS PHARMACEUTICALS, INC.

Sold, on record
$1.8M
Dollars the filings state
Form 4 sales
7
Latest May 12, 2020
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale MARINUS PHARMACEUTICALS, INC.Unusual
    Apr 21 2015

    Sold 30,000 shares at $9.48 ($284k)

    Farfel Gail M, Chief Clinical Dev & Reg Offic

    Sold 100% of holdings ($284k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ZOGENIX, INC.Unusual
    Jun 12 +1148 days

    Sold 5,118 shares at $45.00 ($230k)

    Farfel Gail M, EVP/Chief Development Officer

    Sold 41.7% of holdings ($552k position)7,143 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale ZOGENIX, INC.Unusual
    Aug 8 +57 days

    Sold 7,000 shares at $52.62 ($368k)

    Farfel Gail M, EVP/Chief Development Officer

    Sold 49.5% of holdings ($744k position)7,143 shares leftFiling

  4. 4 Form 4 sale ZOGENIX, INC.Unusual
    Sep 4 +27 days

    Sold 7,000 shares at $47.58 ($333k)

    Farfel Gail M, EVP/Chief Development Officer

    Sold 49.5% of holdings ($673k position)7,143 shares leftFiling

  5. 5 Form 4 sale ZOGENIX, INC.Unusual
    Oct 4 +30 days

    Sold 6,961 shares at $43.23 ($301k)

    Farfel Gail M, EVP/Chief Development Officer

    Sold 49.4% of holdings ($610k position)7,143 shares left1x usual sizeFiling

  6. 6 Form 4 sale ZOGENIX, INC.Unusual
    Aug 22 +322 days

    Sold 3,446 shares at $52.00 ($179k)

    Farfel Gail M, EVP/Chief Development Officer

    Sold 41.3% of holdings ($434k position)4,891 shares left0.5x usual sizeFiling

  7. 7 Form 4 sale ZOGENIX, INC.Unusual
    May 12 +264 days

    Sold 2,573 shares at $28.21 ($73k)

    Farfel Gail M, EVP/Chief Development Officer

    Sold 33.8% of holdings ($215k position)5,048 shares left0.4x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (7)

Form 144 notices and Form 4 sales by Farfel Gail M
Source
May 12, 2020ZOGENIX, INC.EVP/Chief Development OfficerForm 4 sale2,573$73k33.8%UnusualSEC
Aug 22, 2019ZOGENIX, INC.EVP/Chief Development OfficerForm 4 sale3,446$179k41.3%UnusualSEC
Oct 4, 2018ZOGENIX, INC.EVP/Chief Development OfficerForm 4 sale6,961$301k49.4%UnusualSEC
Sep 4, 2018ZOGENIX, INC.EVP/Chief Development OfficerForm 4 sale7,000$333k49.5%UnusualSEC
Aug 8, 2018ZOGENIX, INC.EVP/Chief Development OfficerForm 4 sale7,000$368k49.5%UnusualSEC
Jun 12, 2018ZOGENIX, INC.EVP/Chief Development OfficerForm 4 sale5,118$230k41.7%UnusualSEC
Apr 21, 2015MARINUS PHARMACEUTICALS, INC.Chief Clinical Dev & Reg OfficForm 4 sale30,000$284k100.0%UnusualSEC